Source: BUSINESS WIRE

Press Release: Gene Signal : Research and Markets: Corneal Neovascularization - Global Clinical Trials Review, H2, 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xglzkh/corneal) has announced the addition of the "Corneal Neovascularization Global Clinical Trials Review, H2, 2015" report to their offering. Corneal Neovascularization Global Clinical Trials Review, H2, 2015" provides an overview of Corneal Neovascularization clinical trials scenario. This report provides top line data relating to the clinical trials on Corneal Neovascularization. Report includes an ov

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Eric Viaud's photo - Co-Founder & CEO of Gene Signal

Co-Founder & CEO

Eric Viaud

CEO Approval Rating

81/100

Read more